DOCSLIB.ORG

Mouse Cdhr5 Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Cdhr5 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Cdhr5 Knockout Project (CRISPR/Cas9) Objective: To create a Cdhr5 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cdhr5 gene (NCBI Reference Sequence: NM_001114322 ; Ensembl: ENSMUSG00000025497 ) is located on Mouse chromosome 7. 15 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 15 (Transcript: ENSMUST00000167263). Exon 1~15 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 1 starts from about 0.04% of the coding region. Exon 1~15 covers 100.0% of the coding region. The size of effective KO region: ~7564 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Legends Exon of mouse Cdhr5 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 9 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(21.6% 432) | C(32.4% 648) | T(21.15% 423) | G(24.85% 497) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. Significant high GC-content regions are found. The gRNA site is selected outside of these high GC-content regions. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(24.9% 498) | C(23.1% 462) | T(28.75% 575) | G(23.25% 465) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr7 - 141276719 141278718 2000 browser details YourSeq 100 1381 1621 2000 92.4% chr13 + 58912538 58912803 266 browser details YourSeq 97 1378 1623 2000 84.4% chr7 + 51741021 51741234 214 browser details YourSeq 84 1380 1597 2000 92.2% chr11 - 22506824 22507210 387 browser details YourSeq 78 1404 1630 2000 77.8% chr11 - 80585716 80585853 138 browser details YourSeq 72 1429 1621 2000 93.8% chr13 + 58912529 58912874 346 browser details YourSeq 71 1428 1624 2000 92.8% chr9 + 89880370 89880863 494 browser details YourSeq 70 1407 1623 2000 90.6% chr11 + 104121341 104121561 221 browser details YourSeq 59 1408 1627 2000 95.4% chr12 + 113312179 113312929 751 browser details YourSeq 56 1401 1602 2000 74.2% chr7 + 51741106 51741234 129 browser details YourSeq 56 1382 1619 2000 71.3% chr11 + 34767377 34767499 123 browser details YourSeq 56 1445 1619 2000 74.3% chr11 + 34767216 34767342 127 browser details YourSeq 53 1407 1561 2000 92.1% chr9 + 89880571 89881023 453 browser details YourSeq 47 1546 1630 2000 73.6% chr11 - 80585795 80585853 59 browser details YourSeq 43 1379 1455 2000 93.9% chr11 - 22506890 22507134 245 browser details YourSeq 43 1381 1537 2000 67.4% chr13 + 58912568 58912642 75 browser details YourSeq 40 1385 1457 2000 76.1% chr17 + 44609913 44609972 60 browser details YourSeq 28 1461 1511 2000 71.9% chr10 + 81559837 81559876 40 browser details YourSeq 27 1427 1458 2000 93.8% chr3 + 69902591 69902623 33 browser details YourSeq 26 1549 1585 2000 96.5% chr11 + 104121498 104121539 42 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr7 - 141267153 141269152 2000 browser details YourSeq 428 699 2000 2000 92.9% chr2 + 153311818 153584239 272422 browser details YourSeq 235 1403 2000 2000 88.4% chr17 - 35890263 35890730 468 browser details YourSeq 212 1406 1997 2000 89.9% chr7 - 120872251 120872782 532 browser details YourSeq 209 367 930 2000 84.0% chr8 + 13765633 13766067 435 browser details YourSeq 199 734 1263 2000 89.7% chr18 - 35454740 35731354 276615 browser details YourSeq 193 1123 1997 2000 78.6% chr7 - 126349492 126349858 367 browser details YourSeq 191 1407 1997 2000 84.5% chr4 - 136022739 136022971 233 browser details YourSeq 187 723 1249 2000 83.1% chr12 - 85148893 85149229 337 browser details YourSeq 186 1299 1717 2000 89.1% chr11 + 119272283 119272789 507 browser details YourSeq 178 1403 1722 2000 83.8% chr7 - 34336652 34336925 274 browser details YourSeq 172 705 1250 2000 80.1% chr7 - 81518457 81518790 334 browser details YourSeq 167 707 1227 2000 80.3% chr13 - 43640159 43640461 303 browser details YourSeq 165 367 896 2000 76.7% chr19 + 3827463 3827786 324 browser details YourSeq 165 697 895 2000 90.6% chr11 + 21734471 21734663 193 browser details YourSeq 162 707 893 2000 91.3% chrX + 152087157 152087339 183 browser details YourSeq 161 684 895 2000 90.0% chr10 + 22634280 22634505 226 browser details YourSeq 159 703 911 2000 90.0% chr8 - 13407011 13407258 248 browser details YourSeq 159 705 899 2000 88.8% chr2 - 157196447 157196633 187 browser details YourSeq 156 700 896 2000 92.4% chr16 + 48292071 48292491 421 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 https://www.alphaknockout.com Gene and protein information: Cdhr5 cadherin-related family member 5 [ Mus musculus (house mouse) ] Gene ID: 72040, updated on 12-Aug-2019 Gene summary Official Symbol Cdhr5 provided by MGI Official Full Name cadherin-related family member 5 provided by MGI Primary source MGI:MGI:1919290 See related Ensembl:ENSMUSG00000025497 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Mucdhl; Mupcdh; AI481143; 1810074H01Rik Expression Biased expression in duodenum adult (RPKM 477.0), small intestine adult (RPKM 353.9) and 3 other tissues See more Orthologs human all Genomic context Location: 7; 7 F5 See Cdhr5 in Genome Data Viewer Exon count: 15 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 7 NC_000073.6 (141269080..141276795, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 7 NC_000073.5 (148454984..148462685, complement) Chromosome 7 - NC_000073.6 Page 6 of 9 https://www.alphaknockout.com Transcript information: This gene has 5 transcripts Gene: Cdhr5 ENSMUSG00000025497 Description cadherin-related family member 5 [Source:MGI Symbol;Acc:MGI:1919290] Gene Synonyms 1810074H01Rik, Mucdhl, Mupcdh Location Chromosome 7: 141,269,083-141,276,786 reverse strand. GRCm38:CM001000.2 About this gene This gene has 5 transcripts (splice variants), 90 orthologues, 33 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Cdhr5- ENSMUST00000167263.8 2628 831aa ENSMUSP00000127292.1 Protein coding CCDS52442 A0PJK7 TSL:1 202 GENCODE basic APPRIS ALT2 Cdhr5- ENSMUST00000080654.6 2133 669aa ENSMUSP00000079484.5 Protein coding CCDS22006 Q8VHF2 TSL:1 201 GENCODE basic APPRIS P3 Cdhr5- ENSMUST00000210124.1 1001 333aa ENSMUSP00000148123.1 Protein coding - A0A1B0GSY5 CDS 5' and 3' 203 incomplete TSL:5 Cdhr5- ENSMUST00000210773.1 554 131aa ENSMUSP00000147472.1 Nonsense mediated - A0A1B0GRD3 CDS 5' 205 decay incomplete TSL:5 Cdhr5- ENSMUST00000210386.1 755 No - Retained intron - - TSL:3 204 protein Page 7 of 9 https://www.alphaknockout.com 27.70 kb Forward strand 141.26Mb 141.27Mb 141.28Mb Genes Phrf1-209 >nonsense mediated decay (Comprehensive set... Phrf1-201 >protein coding Phrf1-202 >protein coding Phrf1-207 >protein coding Phrf1-204 >protein coding Phrf1-208 >retained intron Contigs AC163434.5 > Genes < Irf7-203protein coding < Cdhr5-201protein coding < Sct-203retained intron (Comprehensive set... < Irf7-201protein coding < Cdhr5-202protein coding < Sct-201protein coding < Irf7-213retained intron < Cdhr5-205nonsense mediated decay < Sct-204protein coding < Irf7-202protein coding < Cdhr5-203protein coding < Sct-202protein coding < Irf7-210retained intron < Cdhr5-204retained intron < Irf7-212nonsense mediated decay < Irf7-204protein coding < Irf7-206retained intron < Irf7-207lncRNA < Irf7-209retained intron < Irf7-211retained intron < Irf7-205retained intron < Irf7-208lncRNA Regulatory Build 141.26Mb 141.27Mb 141.28Mb Reverse strand 27.70 kb Regulation Legend CTCF Promoter
Load more

Recommended publications
  • Learning from Cadherin Structures and Sequences: Affinity Determinants and Protein Architecture
    Learning from cadherin structures and sequences: affinity determinants and protein architecture Klára Fels ıvályi Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Klara Felsovalyi All rights reserved ABSTRACT Learning from cadherin structures and sequences: affinity determinants and protein architecture Klara Felsovalyi Cadherins are a family of cell-surface proteins mediating adhesion that are important in development and maintenance of tissues. The family is defined by the repeating cadherin domain (EC) in their extracellular region, but they are diverse in terms of protein size, architecture and cellular function. The best-understood subfamily is the type I classical cadherins, which are found in vertebrates and have five EC domains. Among the five different type I classical cadherins, the binding interactions are highly specific in their homo- and heterophilic binding affinities, though their sequences are very similar. As previously shown, E- and N-cadherins, two prototypic members of the subfamily, differ in their homophilic K D by about an order of magnitude, while their heterophilic affinity is intermediate. To examine the source of the binding affinity differences among type I cadherins, we used crystal structures, analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), and electron paramagnetic resonance (EPR) studies. Phylogenetic analysis and binding affinity behavior show that the type I cadherins can be further divided into two subgroups, with E- and N-cadherin representing each. In addition to the affinity differences in their wild-type binding through the strand-swapped interface, a second interface also shows an affinity difference between E- and N-cadherin.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • Genome-Wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma DAOUD M
    CANCER GENOMICS & PROTEOMICS 11 : 1-12 (2014) Genome-wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma DAOUD M. MEERZAMAN 1,2 , CHUNHUA YAN 1, QING-RONG CHEN 1, MICHAEL N. EDMONSON 1, CARL F. SCHAEFER 1, ROBERT J. CLIFFORD 2, BARBARA K. DUNN 3, LI DONG 2, RICHARD P. FINNEY 1, CONSTANCE M. CULTRARO 2, YING HU1, ZHIHUI YANG 2, CU V. NGUYEN 1, JENNY M. KELLEY 2, SHUANG CAI 2, HONGEN ZHANG 2, JINGHUI ZHANG 1,4 , REBECCA WILSON 2, LAUREN MESSMER 2, YOUNG-HWA CHUNG 5, JEONG A. KIM 5, NEUNG HWA PARK 6, MYUNG-SOO LYU 6, IL HAN SONG 7, GEORGE KOMATSOULIS 1 and KENNETH H. BUETOW 1,2 1Center for Bioinformatics and Information Technology, National Cancer Institute, Rockville, MD, U.S.A.; 2Laboratory of Population Genetics, National Cancer Institute, National Cancer Institute, Bethesda, MD, U.S.A.; 3Basic Prevention Science Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, U.S.A; 4Department of Biotechnology/Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, U.S.A.; 5Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; 6Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea; 7Department of Internal Medicine, College of Medicine, Dankook University, Cheon-An, Korea Abstract . We report on next-generation transcriptome Worldwide, liver cancer is the fifth most common cancer and sequencing results of three human hepatocellular carcinoma the third most common cause of cancer-related mortality (1). tumor/tumor-adjacent pairs.
    [Show full text]
  • Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma Thomas G
    Human Cancer Biology Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma Thomas G. Paulson,1,2 Carlo C. Maley,4,5 Xiaohong Li,2 Hongzhe Li,6 Carissa A. Sanchez,1,2 Dennis L. Chao,3 Robert D. Odze,7 Thomas L. Vaughan,2,8 Patricia L. Blount,1,2,10 and Brian J. Reid1,2,9,10 Abstract Purpose: Chromosomal instability, as assessed by many techniques, including DNA content aneuploidy, loss of heterozygosity, and comparative genomic hybridization, has consistently been reported to be common in cancer and rare in normal tissues. Recently, a panel of chromosome instability biomarkers, including loss of heterozygos- ity and DNA content, has been reported to identify patients at high and low risk of pro- gression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA), but required multiple platforms for implementation. Although chromosomal instability in- volving amplifications and deletions of chromosome regions have been observed in nearly all cancers, copy number alterations (CNA) in premalignant tissues have not been well characterized or evaluated in cohort studies as biomarkers of cancer risk. Experimental Design: We examined CNAs in 98 patients having either BE or EA using Bacterial Artificial Chromosome (BAC) array comparative genomic hybridization to char- acterize CNAs at different stages of progression ranging from early BE to advanced EA. Results: CNAs were rare in early stages (less than high-grade dysplasia) but were pro- gressively more frequent and larger in later stages (high-grade dysplasia and EA), in- cluding high-level amplifications. The number of CNAs correlated highly with DNA content aneuploidy.
    [Show full text]
  • WO 2013/095793 Al 27 June 2013 (27.06.2013) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/095793 Al 27 June 2013 (27.06.2013) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12Q 1/68 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US2012/063579 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 5 November 20 12 (05 .11.20 12) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 61/579,530 22 December 201 1 (22. 12.201 1) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: AVEO PHARMACEUTICALS, INC. kind of regional protection available): ARIPO (BW, GH, [US/US]; 75 Sidney Street, Fourth Floor, Cambridge, MA GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, 02139 (US).
    [Show full text]
  • Notate Human RPE-Specific Gene Expression
    UvA-DARE (Digital Academic Repository) Function and pathology of the human retinal pigment epithelium Booij, J.C. Publication date 2010 Link to publication Citation for published version (APA): Booij, J. C. (2010). Function and pathology of the human retinal pigment epithelium. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:25 Sep 2021 A new strategy to identify and an- notate human RPE-specific gene expression 3 Judith C Booij, Jacoline B ten Brink, Sigrid MA Swagemakers, Annemieke JMH Verkerk, Anke HW Essing, Peter J van der Spek, Arthur AB Bergen. PlosOne 2010, 5(3) e9341 Chapter 3 Abstract Background: The aim of the study was to identify and functionally annotate cell type-spe- cific gene expression in the human retinal pigment epithelium (RPE), a key tissue involved in age-related macular degeneration and retinitis pigmentosa.
    [Show full text]
  • Protocadherin in Colorectal Tumours
    Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2015, Article ID 317093, 9 pages http://dx.doi.org/10.1155/2015/317093 Research Article Epigenetic-Mediated Downregulation of -Protocadherin in Colorectal Tumours Bujko Mateusz,1 Kober Paulina,1 Statkiewicz MaBgorzata,2 Mikula Michal,2 Ligaj Marcin,3 Zwierzchowski Lech,4 Ostrowski Jerzy,2 and Siedlecki Janusz Aleksander1 1 Department of Molecular and Translational Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 5W.K.Roentgena,02-781Warsaw,Poland 2Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 5W.K.Roentgena,02-781Warsaw,Poland 3Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 5 W.K. Roentgena, 02-781 Warsaw, Poland 4Department of Molecular Biology, Institute of Genetics and Animal Breeding, 36A Postępu 36A, Jastrzębiec, 05-552 Magdalenka, Poland Correspondence should be addressed to Bujko Mateusz; [email protected] Received 16 November 2014; Accepted 25 March 2015 Academic Editor: Robert Odze Copyright © 2015 Bujko Mateusz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Carcinogenesis involves altered cellular interaction and tissue morphology that partly arise from aberrant expression of cadherins. Mucin-like protocadherin is implicated in intercellular adhesion and its expression was found decreased in colorectal cancer (CRC). This study has compared MUPCDH (CDHR5) expression in three key types of colorectal tissue samples, for normal mucosa, adenoma, and carcinoma. A gradual decrease of mRNA levels and protein expression was observed in progressive stages of colorectal carcinogenesis which are consistent with reports of increasing MUPCDH 5 promoter region DNA methylation.
    [Show full text]
  • Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma Thomas G
    Human Cancer Biology Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma Thomas G. Paulson,1,2 Carlo C. Maley,4,5 Xiaohong Li,2 Hongzhe Li,6 Carissa A. Sanchez,1,2 Dennis L. Chao,3 Robert D. Odze,7 Thomas L. Vaughan,2,8 Patricia L. Blount,1,2,10 and Brian J. Reid1,2,9,10 Abstract Purpose: Chromosomal instability, as assessed by many techniques, including DNA content aneuploidy, loss of heterozygosity, and comparative genomic hybridization, has consistently been reported to be common in cancer and rare in normal tissues. Recently, a panel of chromosome instability biomarkers, including loss of heterozygos- ity and DNA content, has been reported to identify patients at high and low risk of pro- gression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA), but required multiple platforms for implementation. Although chromosomal instability in- volving amplifications and deletions of chromosome regions have been observed in nearly all cancers, copy number alterations (CNA) in premalignant tissues have not been well characterized or evaluated in cohort studies as biomarkers of cancer risk. Experimental Design: We examined CNAs in 98 patients having either BE or EA using Bacterial Artificial Chromosome (BAC) array comparative genomic hybridization to char- acterize CNAs at different stages of progression ranging from early BE to advanced EA. Results: CNAs were rare in early stages (less than high-grade dysplasia) but were pro- gressively more frequent and larger in later stages (high-grade dysplasia and EA), in- cluding high-level amplifications. The number of CNAs correlated highly with DNA content aneuploidy.
    [Show full text]
  • Name Aliases Binding Partner Physiology / Oncology References
    Name Aliases Binding partner Physiology / Oncology References AJAP1 Adherens junction associated protein 1, ? PHY : Expressed in uterus and pancreas. [1] http://www.uniprot.org/uniprot/Q9UKB5. [2] SHREW1 Plays a role in cell adhesion and migration. McDonald JM, Cancer Biol Ther 2006, 5:300-4 Forms a complex with CDH1 and beta-catenin at adherens junctions [1] ONC : Frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration [2] ALCAM Activated leukocyte cell adhesion CD6 PHY : Adhesion of activated leukocytes and [1] Ofori-Acquah SF, Transl Res 2008, 151:122- molecule, CD166, MEMD (melanoma neurons 8. [2] van Kilsdonk JW, Cancer Res 2008, metastasis clone D) 68:3671-9 ONC : Expressed by different tumor types including melanoma; mediates cancer/ melanoma invasiveness [1,2] AMICA1 Adhesion molecule interacting with CXADR PHY : Expression is restricted to the [1] http://www.uniprot.org/uniprot/Q86YT9. [2] CXADR antigen 1, JAML (junctional hematopoietic tissues with the exception of Moog-Lutz C, Blood 2003, 102:3371-8 adhesion molecule-like) liver. May function in transmigration of leukocytes through epithelial and endothelial tissues. Mediates adhesive interactions with CXADR, a protein of the junctional complex of epithelial cells [1] ONC : Enhances myeloid leukemia cell adhesion to endothelial cells [2] AMIGO1 Amphoterin-induced gene and open AMIGO PHY : May be involved in fasciculation as well [1] http://www.uniprot.org/uniprot/Q86WK6 reading frame 1, Alivin-2 as myelination of developing neural axons. May have a role in regeneration as well as neural plasticity in the adult nervous system. May mediate homophilic as well as heterophilic cell-cell interaction and contribute to signal transduction through its intracellular domain [1] ONC : - AMIGO2 Amphoterin-induced gene and open AMIGO PHY : Highest levels in breast, ovary, cervix, [1] http://www.uniprot.org/uniprot/Q86SJ2.
    [Show full text]
  • Supplementary Information
    Supplementary Information Table S1. Regions of CNV data excluded from CNV analysis due to poor density of probe coverage. Region Centromere Telomere Chr. p q p q 1 p11.1, p11.2, q11, q12, q21.1 p36.33, p36.32, p36.31, q44 p12, p13.1 p36.23, p36.22, p36.21 2 p11.1, p11.2 q11.1 p25.3 q37.3 3 p11.1 q11.1, q11.2 none excluded q29 4 p11 q11 p16.1, p16.2, p16.3 q35.2, q35.1 5 p12 q11.1 p15.33 q35.3, q35.2, q35.1 6 p11.1 q11.1 p25.3, p35.2 q27 7 p11.1 q11.1, q11.21 p22.3 q36.3 8 p11.1 q11.1 p23.3, p23.2, p23.1 q24.3 9 p11.1, p11.2 q11, q12, q13 p24.3 q34.3, q34.2, q34.13, q34.12, q34.11 10 p11.1 q11.1, q11.21, q11.22 none excluded q26.3 11 p11.11, p11.12 q11 p15.5 q25 12 p11.1, p11.21 q11 p13.33, p13.32 q24.33, q24.32, q24.31 13 no probes q11 no probes q34 14 no probes q11.1, q11.2 no probes q32.33 15 no probes q11.1, q11.2, q12, no probes q26.3 q13.1, q13.2, q13.3 16 p11.1, p11.2 q11.1, q11.2 p13.3 q24.3, q24.2, q24.1 17 none excluded none excluded p13.3 q25.3 18 p11.1, p11.21 q11.1 none excluded q23 19 p11 q11 p13.3 q13.43 20 p11.1, p11.21 q11.1, q11.21 none excluded q13.33 21 no probes q11.1, q11.2 no probes q22.3 22 no probes q11.1, q11.21, q11.22 no probes q13.33, q13.32 Table S2.
    [Show full text]
  • A New Strategy to Identify and Annotate Human RPE-Specific Gene Expression
    A New Strategy to Identify and Annotate Human RPE-Specific Gene Expression Judith C. Booij1, Jacoline B. ten Brink1, Sigrid M. A. Swagemakers2,3, Annemieke J. M. H. Verkerk2, Anke H. W. Essing1, Peter J. van der Spek2, Arthur A. B. Bergen1,4,5* 1 Department of Clinical and Molecular Ophthalmogenetics, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands, 2 Department of Bioinformatics and Genetics, Erasmus Medical Center, Rotterdam, The Netherlands, 3 Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, The Netherlands, 4 Clinical Genetics Academic Medical Centre Amsterdam, University of Amsterdam, The Netherlands, 5 Department of Ophthalmology, Academic Medical Centre Amsterdam, University of Amsterdam, The Netherlands Abstract Background: To identify and functionally annotate cell type-specific gene expression in the human retinal pigment epithelium (RPE), a key tissue involved in age-related macular degeneration and retinitis pigmentosa. Methodology: RPE, photoreceptor and choroidal cells were isolated from selected freshly frozen healthy human donor eyes using laser microdissection. RNA isolation, amplification and hybridization to 44 k microarrays was carried out according to Agilent specifications. Bioinformatics was carried out using Rosetta Resolver, David and Ingenuity software. Principal Findings: Our previous 22 k analysis of the RPE transcriptome showed that the RPE has high levels of protein synthesis, strong energy demands, is exposed to high levels of oxidative stress and a variable degree of inflammation. We currently use a complementary new strategy aimed at the identification and functional annotation of RPE-specific expressed transcripts. This strategy takes advantage of the multilayered cellular structure of the retina and overcomes a number of limitations of previous studies.
    [Show full text]
  • Chromosomal Instability and Copy Number Alterations in Barrett's
    Chromosomal instability and copy number alterations in Barrett’s esophagus and esophageal adenocarcinoma Thomas G. Paulson1,2,10, Carlo C. Maley4, Xiaohong Li2, Hongzhe Li5, Carissa A. Sanchez1,2, Dennis L. Chao3, Robert D. Odze6, Thomas L. Vaughan2,7, Patricia L. Blount1,2,9, Brian J. Reid1,2,8,9 1Divisions of Human Biology, 2Public Health Sciences, and the 3Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA; 4Molecular and Cellular Oncogenesis Program, Systems Biology Division, The Wistar Institute, Philadelphia, PA and Genomics and Computational Biology Graduate Program and Cellular and Molecular Biology Graduate Program, University of Pennsylvania, Philadelphia, PA; 5Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA; 6Department of Pathology, Brigham and Women’s Hospital, Boston, MA; 7Departments of Epidemiology, 8Genome Sciences and 9Medicine, University of Washington, Seattle, WA; 10Corresponding author Brian J. Reid, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, C1-157, Seattle, WA, 98109. Supported by NIH K07CA089147, PO1CA91955 and the Ryan Hill Foundation (TGP). Running Title: Copy number alterations in Barrett’s esophagus Key words: copy number alteration, Barrett’s esophagus, esophageal adenocarcinoma, array CGH, premalignant, aneuploidy, chromosomal instability 1 Statement of Clinical Relevance Barrett’s esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EA), but the vast majority of patients with BE will die of unrelated causes. Identification of biomarkers that discriminate between patients at low vs. high risk of progressing to cancer is necessary to improve patient outcomes. Here, we report an array comparative genomic hybridization (CGH) analysis of copy number alterations in a cohort of 98 patients with either premalignant BE or EA.
    [Show full text]